AU1940800A - Combination therapy for the treatment of sepsis - Google Patents

Combination therapy for the treatment of sepsis

Info

Publication number
AU1940800A
AU1940800A AU19408/00A AU1940800A AU1940800A AU 1940800 A AU1940800 A AU 1940800A AU 19408/00 A AU19408/00 A AU 19408/00A AU 1940800 A AU1940800 A AU 1940800A AU 1940800 A AU1940800 A AU 1940800A
Authority
AU
Australia
Prior art keywords
sepsis
treatment
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19408/00A
Inventor
Ronald Steven Maciak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1940800A publication Critical patent/AU1940800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4866Protein C (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU19408/00A 1998-12-21 1999-12-20 Combination therapy for the treatment of sepsis Abandoned AU1940800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11312498P 1998-12-21 1998-12-21
US60113124 1998-12-21
PCT/US1999/030433 WO2000037022A2 (en) 1998-12-21 1999-12-20 Combination therapy for the treatment of sepsis

Publications (1)

Publication Number Publication Date
AU1940800A true AU1940800A (en) 2000-07-12

Family

ID=22347698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19408/00A Abandoned AU1940800A (en) 1998-12-21 1999-12-20 Combination therapy for the treatment of sepsis

Country Status (5)

Country Link
EP (1) EP1214041A2 (en)
JP (1) JP2002542148A (en)
AU (1) AU1940800A (en)
CA (1) CA2358492A1 (en)
WO (1) WO2000037022A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4459441B2 (en) * 1998-05-01 2010-04-28 塩野義製薬株式会社 sPLA2 inhibitor ester
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
WO2002005796A2 (en) * 2000-07-14 2002-01-24 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
WO2002100445A1 (en) 2001-06-13 2002-12-19 The University Of Sydney Treatment and composition for wound healing
US9353113B2 (en) 2011-03-18 2016-05-31 Ono Pharmaceutical Co., Ltd. Tetrahydrocarboline derivative
WO2016116527A1 (en) * 2015-01-20 2016-07-28 Cynora Gmbh Organic molecules, in particular for use in optoelectronic components

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
ES2377223T3 (en) * 1994-04-01 2012-03-23 Eli Lilly And Company [[3- (2-Amino-1,2-dioxoethyl) -2-ethyl-1- (phenylmethyl) -11H-indole-4-IL] oxy] acetic acid methyl ester as an inhibitor of sPLA2
DZ2769A1 (en) * 1998-04-17 2003-12-01 Lilly Co Eli Substituted tricyclics.

Also Published As

Publication number Publication date
EP1214041A2 (en) 2002-06-19
CA2358492A1 (en) 2000-06-29
WO2000037022A2 (en) 2000-06-29
WO2000037022A3 (en) 2002-06-13
JP2002542148A (en) 2002-12-10

Similar Documents

Publication Publication Date Title
AU2301699A (en) System for the treatment of wafers
HUP0100765A3 (en) Composition for the treatment of halitosis
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2935200A (en) Compounds for the treatment of obesity
AU2212299A (en) Compositions and methods for the treatment of tumor
AU3891299A (en) Combination therapy for treatment of depression
AU2882299A (en) Anti-asthma therapy
IL142588A0 (en) Therapy for improving cognition
AU2508597A (en) Drug for the treatment of tumours
AU1772399A (en) Well treatment
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU5038299A (en) Process for the biocidal treatment of surfaces
AU2740899A (en) Treatment of liquids
AU5056099A (en) Compounds for use in the treatment of inflammation
AU3187595A (en) Compounds for the treatment of restenosis
HUP0101947A3 (en) Combination for the treatment of tumors
AU2021601A (en) Composition for the treatment of dandruff
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU1940800A (en) Combination therapy for the treatment of sepsis
IL135994A0 (en) Combination therapy for the treatment of aids
AU4032799A (en) Device for the treatment of bottles
AU2566201A (en) Compounds and methods for the treatment of pain
AUPP375198A0 (en) An anticorrosion treatment
AU1594397A (en) Use of colostrum for the treatment of constipation
AUPP229598A0 (en) Treatment of sunburn

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase